• Change country/language

    Looks like you’re in {} — you’re on the {} site.

    Cancel

    Country and language selected

    You are being redirected to the {} site. Products and services availability vary by country. Do you wish to continue?

    Continue
    Cancel

Precision care: from aspiration to reality for all patients

Image13

One goal: personalized care.  Five leaders share perspectives on why precision care should be the standard of care for all. 

Q: What does precision care look like when it’s working?

A: Pete Arduini, President and CEO, GE HealthCare

Precision care is working when data, devices, and drugs are connected longitudinally across the entire patient journey — from screening to diagnosis, treatment, and monitoring — helping clinicians make informed decisions at every stage.  

It’s when imaging moves beyond detecting disease to actively shaping how it’s treated, helping guide therapeutic decisions in real time and enabling fewer invasive options that can reduce recovery times. AI and cloud-based solutions help bring together data and information that once sat in silos, enabling the right information to move with the patient throughout their care journey and multi-disciplinary care teams to collaborate on a more personalized and precise plan for each patient.

As treatments become more targeted and personalized, imaging has an even more important role to play, providing the insights clinicians need to answer increasingly precise questions: which treatment is right for this patient, when, and is it working?  

The result is helping patients through earlier detection, more targeted treatment, and helping patients receive the right treatment, and potentially a sooner cure, with clinicians focusing on what matters most: the patient. 

Q: Why can’t precision care be one-size-fits-all?

A: Catherine Estrampes, Chief Commercial and Growth Officer, GE HealthCare

Just as patients have unique treatment plans for common health conditions, the solutions to health systems’ shared challenges are not one-size-fits-all. As we look at precision care for patients, it’s a similar “precision” needed for the clinicians, hospitals, and health systems that care for them. Some are expanding to a new geographic area, merging with another health system, or expanding outpatient care settings, while some others face cost constraints and workforce shortages.

To realize this vision, where much of a health system and the patient experience is interconnected, co-developed tailored solutions at the enterprise-level are necessary to advance progress in not just healthcare, but precision care. 

Q: What gets in the way of precision care today and how can we innovate to improve outcomes for all?

A: Phil Rackliffe, President and CEO, Advanced Imaging Solutions, GE HealthCare

Healthcare is not short of data or technology. The obstacle is how we better connect the right information reaching the right clinician at the right moment to support the right decision for a patient’s unique care plan. Innovation can close that gap by starting from a patient’s care plan, to inform the right decision, rather than from what a single tool or technology can do on its own.

In product development, that translates to innovative tools and technologies that connect across detection, diagnosis, treatment planning and monitoring so clinical teams can see the full picture. It also means integrating AI thoughtfully across clinical workflows that care teams use today to help connect information, so clinicians aren’t left to piece together a patient’s story themselves.

Precision care moves from promise to practice when we effectively work together to help healthcare teams and providers answer clinical questions and make more informed decisions to deliver more personalized care to patients around the world.

Q: Why is nuclear medicine so central to precision care?

A: Kevin O’Neill, President and CEO, Pharmaceutical Diagnostics (PDx)

Nuclear medicine allows us to see how disease behaves at a molecular level, not simply where it is located. By combining radiopharmaceuticals with advanced imaging technologies, we can gain functional information that can help clinicians make more informed and tailored decisions for patients with conditions including cancer, heart disease and neurological disorders.

As precision care advances, our challenge is no longer innovation alone. We also need to ensure these capabilities can reach the patients who may benefit from them. Access to nuclear medicine varies across markets and care settings, shaped by factors including infrastructure, reimbursement, trained specialists, clinical pathways and radiopharmaceutical availability. The future of precision care must therefore be about translating scientific progress into accessible clinical impact, wherever patients receive care.

Q: Where can AI help take precision care?

A: Rodolphe Katra, Global Chief AI Officer, GE HealthCare

AI is a great tool for making sense of patterns in both qualitative and numerical data and can help clinicians consider a broader spectrum of factors into a patient’s unique care plan.  For example, we’ve traditionally focused on hospitalization or survival rates or measures tracked in clinical trials.  

With AI at a personalized level, we can account for what a patient wants to accomplish upon diagnosis after a significant surgery—for example, someone looking to run marathons versus someone getting through the day without pain.  Understanding these highly individual goals allows clinicians to tailor the surgical plan and treatment to each patient’s priorities, rather than relying solely on treatment plans defined by established medical standards.  

Ultimately, AI is a means to an end. At its core, it is math. While exciting math, as a healthcare industry, we’ll need to judge it by what we can achieve: better patient outcomes.  That is precision care at its best: care that fits the person, not just the diagnosis.

Sign Up

We’re sorry, a problem occurred with the form. Please try again.
Thank you for your inquiry

We will be in touch soon.

Something went wrong

We will check and get back.

JB40709XX November 2026